Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases

BACKGROUND: We previously reported mass spectrometry-based proteomic discovery research to identify novel plasma proteins related to the risk of coronary heart disease (CHD) and stroke, and to identify proteins with concentrations affected by the use of postmenopausal hormone therapy. Here we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Prentice, Ross L, Zhao, Shanshan, Johnson, Melissa, Aragaki, Aaron, Hsia, Judith, Jackson, Rebecca D, Rossouw, Jacques E, Manson, JoAnn E, Hanash, Samir M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971342/
https://www.ncbi.nlm.nih.gov/pubmed/24373343
http://dx.doi.org/10.1186/gm517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971342/
https://www.ncbi.nlm.nih.gov/pubmed/24373343
http://dx.doi.org/10.1186/gm517

Ejemplares similares